Orion Oyj Past Earnings Performance
Past criteria checks 6/6
Orion Oyj has been growing earnings at an average annual rate of 6.3%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 3.8% per year. Orion Oyj's return on equity is 38.5%, and it has net margins of 26.1%.
Key information
6.3%
Earnings growth rate
6.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 14.1% |
| Revenue growth rate | 3.8% |
| Return on equity | 38.5% |
| Net Margin | 26.1% |
| Next Earnings Update | 27 Apr 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Orion Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 1,341 | 350 | 279 | 136 |
| 30 Sep 22 | 1,323 | 351 | 275 | 138 |
| 30 Jun 22 | 1,072 | 202 | 250 | 125 |
| 31 Mar 22 | 1,043 | 192 | 245 | 125 |
| 31 Dec 21 | 1,041 | 194 | 238 | 118 |
| 30 Sep 21 | 1,020 | 187 | 231 | 115 |
| 30 Jun 21 | 1,029 | 192 | 235 | 118 |
| 31 Mar 21 | 1,067 | 212 | 235 | 122 |
| 31 Dec 20 | 1,078 | 220 | 245 | 123 |
| 30 Sep 20 | 1,097 | 240 | 254 | 118 |
| 30 Jun 20 | 1,131 | 260 | 258 | 121 |
| 31 Mar 20 | 1,090 | 225 | 265 | 120 |
| 31 Dec 19 | 1,051 | 200 | 264 | 119 |
| 30 Sep 19 | 1,039 | 209 | 255 | 114 |
| 30 Jun 19 | 977 | 172 | 250 | 110 |
| 31 Mar 19 | 971 | 187 | 244 | 105 |
| 31 Dec 18 | 978 | 197 | 238 | 104 |
| 30 Sep 18 | 981 | 198 | 237 | 103 |
| 30 Jun 18 | 1,001 | 206 | 236 | 102 |
| 31 Mar 18 | 1,015 | 206 | 238 | 101 |
| 31 Dec 17 | 1,034 | 219 | 237 | 99 |
| 30 Sep 17 | 1,048 | 212 | 244 | 111 |
| 30 Jun 17 | 1,065 | 242 | 246 | 114 |
| 31 Mar 17 | 1,077 | 253 | 245 | 118 |
| 31 Dec 16 | 1,074 | 249 | 243 | 118 |
| 30 Sep 16 | 1,055 | 241 | 235 | 112 |
| 30 Jun 16 | 1,036 | 214 | 233 | 108 |
| 31 Mar 16 | 1,018 | 206 | 232 | 108 |
Quality Earnings: ORNAVH has high quality earnings.
Growing Profit Margin: ORNAVH's current net profit margins (26.1%) are higher than last year (18.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ORNAVH's earnings have grown by 6.3% per year over the past 5 years.
Accelerating Growth: ORNAVH's earnings growth over the past year (80.3%) exceeds its 5-year average (6.3% per year).
Earnings vs Industry: ORNAVH earnings growth over the past year (80.3%) exceeded the Pharmaceuticals industry -41.9%.
Return on Equity
High ROE: ORNAVH's Return on Equity (38.5%) is considered high.